第VIII因子欠乏症治療の世界市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Factor VIII Deficiency Treatment Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Highlights

PART 05: Deficiency overview

PART 06: Pipeline analysis

PART 07: Market landscape
• Market overview
• Five forces analysis

PART 08: Market segmentation by type of disease application
• Global hemophilia A drugs market
• Global hemophilia A inhibitors treatment market
• Global von Willebrand disease treatment market

PART 09: Market segmentation by type of therapy
• Recombinant therapies
• Plasma-derived therapies

PART 10: Market segmentation by type of disease management
• Prophylaxis
• On-demand therapy
• Inhibitor therapy

PART 11: Geographical segmentation
• Factor VIII deficiency treatment market in Americas
• Factor VIII deficiency treatment market in EMEA
• Factor VIII deficiency treatment market in APAC

PART 12: Market drivers
• Increasing adoption of prophylactic drugs
• Paradigm shift toward the development of drugs with extended half-life
• Large patient pool driving the shipments of factor VIII units

PART 13: Impact of drivers

PART 14: Market challenges
• Low diagnosis rate affecting the market growth
• High entry barriers
• Cost-intensive complex treatment

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Increase in technological innovations
• Development of gene therapy products
• Expansion initiatives of vendors fueling the market growth
• Increasing investments of vendors to improve the production capability

PART 17: Vendor landscape
• Competitive scenario

PART 18: Key vendor analysis
• Bayer HealthCare
• CSL
• Grifols
• Novo Nordisk
• Pfizer
• Shire
• Other prominent vendors

PART 19: Appendix
• List of abbreviation

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Process of gene therapy
Exhibit 03: Key buying criteria for global factor VIII deficiency treatment market 2016 and 2021
Exhibit 04: Key customer segments of factor VIII deficiency treatment market
Exhibit 05: Pipeline analysis as of 2016
Exhibit 06: Key clinical trials
Exhibit 07: Global factor VIII deficiency treatment market snapshot
Exhibit 08: Global factor VIII deficiency treatment market 2016-2021 ($ billions)
Exhibit 09: Global factor VIII deficiency treatment market by volume 2016-2021 (million units)
Exhibit 10: Impact of factors affecting the market 2016 and 2021
Exhibit 11: Opportunity analysis in global factor VIII deficiency treatment market
Exhibit 12: Five forces analysis
Exhibit 13: Global factor VIII therapy in hemophilia A market 2016-2021 ($ millions)
Exhibit 14: Global factor VIII therapy in hemophilia A inhibitors market 2016-2021 ($ millions)
Exhibit 15: Global factor VIII therapy in von Willebrand disease treatment market 2016-2021 ($ millions)
Exhibit 16: Recombinant therapies in global factor VIII deficiency treatment market 2016-2021 ($ billions)
Exhibit 17: Plasma-derived therapies in global factor VIII deficiency treatment market 2016-2021 ($ billions)
Exhibit 18: Segmentation of factor VIII drugs market by type of disease management based on revenue 2016
Exhibit 19: Segmentation of global factor VIII deficiency treatment market based on geography 2016 and 2021
Exhibit 20: Factor VIII deficiency treatment market revenue by geography 2016-2021 (%)
Exhibit 21: Market scenario in Americas
Exhibit 22: Factor VIII deficiency treatment market in Americas 2016-2021 ($ billions)
Exhibit 23: Market scenario in EMEA
Exhibit 24: Factor VIII deficiency treatment market in EMEA 2016-2021 ($ billions)
Exhibit 25: Market scenario in APAC
Exhibit 26: Factor VIII deficiency treatment market in APAC 2016-2021 ($ billions)
Exhibit 27: Incidence rates of factor VIII deficiency
Exhibit 28: YoY shipments of factor VIII units 2012-2016 (million units)
Exhibit 29: Impact of drivers
Exhibit 30: Diagnosis and treatment trends of hemophilia A 2013
Exhibit 31: Percentage share of diagnosed and undiagnosed hemophilia population 2012-2016
Exhibit 32: Forcefield analysis of drivers and challenges
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Competitive structure analysis of global factor VIII deficiency treatment market 2016
Exhibit 35: Competitive analysis of global factor VIII deficiency treatment market
Exhibit 36: Market share analysis 2016
Exhibit 37: Market penetration of various factor VIII manufacturers worldwide 2016
Exhibit 38: Strategic success factors of companies in global factor VIII deficiency treatment market
Exhibit 39: Key highlights
Exhibit 40: Bayer HealthCare: Strength assessment
Exhibit 41: Bayer HealthCare: Strategy assessment
Exhibit 42: Bayer HealthCare: Opportunity assessment
Exhibit 43: Bayer HealthCare: YoY revenue and growth rate of Kogenate 2013-2015 ($ billions)
Exhibit 44: Key highlights
Exhibit 45: CSL: Strength assessment
Exhibit 46: CSL: Strategy assessment
Exhibit 47: CSL: Opportunity assessment
Exhibit 48: Key highlights
Exhibit 49: Grifols: Strength assessment
Exhibit 50: Grifols: Strategy assessment
Exhibit 51: Grifols: Opportunity assessment
Exhibit 52: YoY growth rate and revenue of bioscience segment 2013-2015 ($ billions)
Exhibit 53: Key highlights
Exhibit 54: Novo Nordisk: Strength assessment
Exhibit 55: Novo Nordisk: Strategy assessment
Exhibit 56: Novo Nordisk: Opportunity assessment
Exhibit 57: Novo Nordisk: YoY revenue and growth of hemophilia segment 2013-2015
Exhibit 58: Key highlights
Exhibit 59: Pfizer: Strength assessment
Exhibit 60: Pfizer: Strategy assessment
Exhibit 61: Pfizer: Opportunity assessment
Exhibit 62: Pfizer: YoY revenue and growth rate of Xyntha/ReFacto AF 2013-2015 ($ millions)
Exhibit 63: Key highlights
Exhibit 64: Shire: Strength assessment
Exhibit 65: Shire: Strategy assessment
Exhibit 66: Shire: Opportunity assessment
Exhibit 67: Baxalta: YoY revenue comparison of hemophilia segment 2013-2015 ($ billions)
Exhibit 68: Baxalta: Geographic segmentation of hemophilia by revenue 2015


【レポート販売概要】

■ タイトル:第VIII因子欠乏症治療の世界市場2017-2021
■ 英文:Global Factor VIII Deficiency Treatment Market 2017-2021
■ 発行日:2017年3月6日
■ 調査会社:Technavio
■ 商品コード:IRTNTR12140
■ 調査対象地域:グローバル
  • グローライトの世界市場2019-2023
    Global Grow Light Market: About this market Technavio’s grow light market analysis considers sales from HID lights, LED lights, fluorescent lights, and others. Our analysis also considers the sales of grow light in APAC, Europe, North America, South America, and MEA. In 2018, the HID light segment had a significant market share. However, the LED light segment will have the largest market share dur …
  • ガラスパッケージ(包装)の世界市場
    Glass packaging is facing increasing competition from rival packaging materials that are stronger, lighter and cheaper to manufacture and transport, as experienced in many of the glass packaging submarkets. Glass is seven times heavier than the equivalent volume of plastic, a significant difference. This means that glass packaging is more expensive to transport than rival materials. Moreover, glas …
  • Bill Barrett Corporation社の石油・ガス開発・生産動向及びコスト分析(2013年第4四半期)
    Bill Barrett Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Bill Barrett Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
  • 油圧ショベルの世界市場:クローラ式油圧ショベル、ミニ油圧ショベル
    About excavators Excavators are used to unearth, transport, and unload materials with the help of a bucket fitted to a boom. They move on crawlers or wheels. Excavators are versatile heavy construction machines used for below- and above-ground operations, including land leveling, digging trenches, and sinking wells. The global excavator market witnessed a healthy growth of 10.24% Y-o-Y in 2014, as …
  • HER2陰性乳癌治療薬の世界市場予測および分析
    PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-negative breast cancer market, with coverage of multiple settings …
  • 世界の研磨布紙市場2015
    The Global Coated Abrasives Industry Report 2015 is a professional and in-depth study on the current state of the Coated Abrasives industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Coated Abrasives market analysis is provided for the international markets including development trends, competitive lan …
  • 世界のヘルスケアにおけるIoT市場:コンポーネント別(医療機器、システム&ソフトウェア、サービス、接続技術)、用途別(テレメディシン、コネクテッドイメージング、入院患者モニタリング)、エンドユーザー別、地域別
    The global Internet of Things (IoT) in healthcare market size to grow at a CAGR of 27.6% during the forecast period The IoT in healthcare market size is projected to grow from USD 55.5 billion in 2019 to USD 188.0 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 27.6% during the forecast period. The IoT in healthcare market is driven by factors, such as advancement in technology coupled …
  • 解凍装置の世界市場予測(~2022年):種類、サンプル(血、血漿、RBC、血小板、全血、胎芽、精液)、エンドユーザー
    The global thawing system market is expected to reach USD 252.7 Million by 2022 from USD 139.6 Million in 2017, at a CAGR of 12.6%. The market growth is primarily driven by the growing incidence of chronic diseases and technological advancements in thawing devices. The global thawing system market is segmented by type, sample type, end user, and region. By type, the thawing system market is segmen …
  • 世界のComplex Event Processing (CEP)市場
    As current market scenario is increasingly competitive and highly complex, thereby demands to execute large business deals, operation level decisions and recognizing risk events ‘before hand’ is even more challenging. As well, it is essential to maintain a minimum amount of latency alongside to have sustainable business environment. Further, the circumstances are intensified by an ever-expanding s …
  • データセンターラックの世界市場2015-2019
    About Data Center Rack A data center rack is a physical framework for housing servers, storage units, networking equipment, cables, and other data center devices. Racks incorporate features, such as provisions for cooling, slots for PDUs, and cable management options located above and below the rack enclosures. Vendors are engaged in various product innovations, like remote monitoring systems into …
  • 乳製品代替飲料のグローバル市場(2014-2018)
    About Dairy Alternative Beverages Dairy alternative beverages are the plant-based milk which is processed through cereals, nuts, and seeds. Dairy alternative beverages are primarily consumed by vegans, the lactose or dairy intolerant, and people with milk allergies. Furthermore, dairy alternative beverages have a low fat content and a low cholesterol level, as they are plant-based. Therefore, the …
  • コンテナ型データセンターの世界市場2015-2019
    About Containerized Data Center A containerized data center is a portable data center pre-installed inside a shipping container. This data center is a part of the modular data center, where each module is a container; the container can host IT, and power and cooling equipment. This data center is available in 20 ft- and 40 ft-long sizes and is delivered to end-users on demand. A wide range of rack …
  • 世界の合成ガス&誘導体市場:生産技術別、ガス化装置種類別、原料別(石炭、天然ガス、石油副産物、バイオマス/廃棄物)、用途別(化学、燃料、電気)、地域別
    The syngas & derivatives market is projected to grow at a CAGR of 12.6% between 2019 and 2024 The syngas & derivatives market is estimated at 277,507 MWth and is projected to reach 501,932 MWth by 2024, at a CAGR of 12.6% from 2019 to 2024. Rising environmental concerns have been the major drivers for the growth of the syngas & derivatives market in order to provide alternative methods of fuel pro …
  • 世界のトップ10 SDx・ネットワーク技術市場
    “The increasing need for simplified network architecture and enhanced security is expected to drive the growth of the software-defined everything and networking technologies”The top 10 Software-Defined Everything (SDx) and networking technologies market is expected to grow at a significant rate between 2016 and 2021. This report covers the major SDx and networking technologies, such as Software-De …
  • グラフ分析の世界市場予測:コンポーネント別、組織規模別、用途別、業種別
    The global graph analytics market size to grow at a CAGR of 34.0% during the forecast periodThe graph analytics market size is projected to grow from USD 584 million in 2019 to USD 2,522 million by 2024, at a Compound Annual Growth Rate (CAGR) of 34.0% during the forecast period. The graph analytics market is driven by the growing demand to analyze low-latency queries, advancements in graph analyt …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。